Featured Research

from universities, journals, and other organizations

Researchers Determine Three Dimensional Structure Of Melatonin Producing Enzyme

Date:
February 3, 1999
Source:
NIH-National Institute Of Child Health And Human Development
Summary:
Researchers from two NIH institutes have determined the three-dimensional structure of an enzyme that produces melatonin--a key hormone that regulates the body's internal clock. The accomplishment may lead to the eventual design of drugs to fight jet lag, to help shift workers adjust to variable schedules, and to combat depression.

Researchers from two NIH institutes have determined the three-dimensional structure of an enzyme that produces melatonin--a key hormone that regulates the body's internal clock. The accomplishment may lead to the eventual design of drugs to fight jet lag, to help shift workers adjust to variable schedules, and to combat depression.

The finding, appearing in the January issue of Molecular Cell, represents the first time that the structure of a protein involved in regulating the body's day/night rhythms has been determined.

The authors of the paper were Alison Burgess Hickman and David C. Klein, of the Laboratory of Developmental Neurobiology at the National Institute of Child Health and Human Development (NICHD) and Fred Dyda, of the Laboratory of Molecular Biology at the National Institute of Diabetes and Digestive and Kidney Diseases.

Briefly, Dr. Klein explained, melatonin is made in the pineal gland of the brain from the brain chemical, serotonin, with the help of two enzymes: arylalkylamine N-acetyl transferase (AA-NAT) and hydroxyindole-O-methyl transferase (HIOMT). AA-NAT appears to be the "melatonin rhythm enzyme," because a large increase in the activity of AA-NAT is responsible for the high levels of melatonin found in the brain and in the bloodstream at night.

Similarly, low levels of melatonin formed during the day reflect low levels of this enzyme. This difference in day and night levels of melatonin is important for setting the body's circadian clock.

In the current paper, the three NIH researchers determined the three dimensional structure of AA-NAT. This advance will allow researchers to more precisely determine how melatonin is produced in response to darkness, and how production is switched off in response to light. In the Molecular Cell paper, the investigators wrote that such knowledge may, in turn, lead to the eventual design of drugs to that would prevent AA-NAT from being produced or destroyed. A drug interfering with AA-NAT production might promote wakefulness, and a drug preventing the enzyme from being degraded might enhance sleep. Similarly, a drug that inhibits AA-NAT might provide a way to elevate brain levels of serotonin, thereby providing a treatment for serotonin-related diseases, such as depression.


Story Source:

The above story is based on materials provided by NIH-National Institute Of Child Health And Human Development. Note: Materials may be edited for content and length.


Cite This Page:

NIH-National Institute Of Child Health And Human Development. "Researchers Determine Three Dimensional Structure Of Melatonin Producing Enzyme." ScienceDaily. ScienceDaily, 3 February 1999. <www.sciencedaily.com/releases/1999/02/990203083230.htm>.
NIH-National Institute Of Child Health And Human Development. (1999, February 3). Researchers Determine Three Dimensional Structure Of Melatonin Producing Enzyme. ScienceDaily. Retrieved August 1, 2014 from www.sciencedaily.com/releases/1999/02/990203083230.htm
NIH-National Institute Of Child Health And Human Development. "Researchers Determine Three Dimensional Structure Of Melatonin Producing Enzyme." ScienceDaily. www.sciencedaily.com/releases/1999/02/990203083230.htm (accessed August 1, 2014).

Share This




More Health & Medicine News

Friday, August 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Vaccine Might Be Coming, But Where's It Been?

Ebola Vaccine Might Be Coming, But Where's It Been?

Newsy (Aug. 1, 2014) Health officials are working to fast-track a vaccine — the West-African Ebola outbreak has killed more than 700. But why didn't we already have one? Video provided by Newsy
Powered by NewsLook.com
Study Links Certain Birth Control Pills To Breast Cancer

Study Links Certain Birth Control Pills To Breast Cancer

Newsy (Aug. 1, 2014) Previous studies have made the link between birth control and breast cancer, but the latest makes the link to high-estrogen oral contraceptives. Video provided by Newsy
Powered by NewsLook.com
House Republicans Vote to Sue Obama Over Healthcare Law

House Republicans Vote to Sue Obama Over Healthcare Law

Reuters - US Online Video (July 31, 2014) The Republican-led House of Representatives votes to sue President Obama, accusing him of overstepping his executive authority in making changes to the Affordable Care Act. Mana Rabiee reports. Video provided by Reuters
Powered by NewsLook.com
Uganda on Alert for Ebola but No Confirmed Cases

Uganda on Alert for Ebola but No Confirmed Cases

AFP (July 31, 2014) Uganda's health minister said on Thursday that there are no confirmed cases of Ebola in the country, but that it remained on alert for cases of the deadly virus. Uganda has suffered Ebola outbreaks in the past, most recently in 2012. Duration: 00:59 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins